Antidepressant, Depressive Disorder, Mental Health, Pharmacogenetic Testing
Conditions
Brief summary
The aim of this study is to investigate if personalized dosing of antidepressant medications using information gathered at the Personalized Medicine Clinic can improve patients' mental health. The main question it aims to answer is if the Personalized Medicine Clinic can improve depressive symptoms based on the CES-D survey score.
Interventions
OTHERPersonalized Medicine Clinic
Personalized Medicine Clinic services with specific focus on pharmacogenetic recommendations and patient education.
Sponsors
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Depressive symptoms
Exclusion criteria
* Patients who do not speak English * Patients with severe mental illness including hospitalized patients or patients with suicidal ideation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| CES-D Survey Score | From enrollment to 6 months | CES-D survey score is a 20-item self-reported questionnaire that was designed to assess depressive symptoms. The score is from 0-60 with higher numbers indicating greater depressive symptoms. |
Contacts
CONTACTRichard B Kim, MD
CONTACTDenise Keller, PharmD
Outcome results
None listed